EMERGENT BIOSOLUTIONS INC (EBS)       12.3  +0.53 (+4.5%)

12.3  +0.53 (+4.5%)

US29089Q1058 - Common Stock - After market: 12.32 +0.02 (+0.16%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -1.27 -0.06 -1.21-1,938.96% Q2 2022 -0.86 0.38 -1.24-327.06% Q1 2022 0.18 0.13 0.0542.57% Q4 2021 4.50 4.31 0.194.38% Q3 2021 -0.36 2.37 -2.73-115.18% Q2 2021 0.33 1.56 -1.23-78.83% Q1 2021 1.53 1.13 0.4034.91% Q4 2020 3.67 3.22 0.4514.01%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -0.05 6.00 -100.91%Q4 2022 0.21 4.50 -95.25%FY 2023 1.88 -0.05 3,540.74%Q1 2023 -0.15 0.18 -186.04%Q2 2023 0.23 -0.86 126.23%Q3 2023 0.14 -1.27 111.40%Q4 2023 0.72 0.21 237.00%FY 2024 2.79 1.88 48.41%FY 2025 6.89 2.79 147.52%FY 2026 17.23 6.89 150.00%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 240M 270.98M -30.98M-11.43% Q2 2022 242.7M 273.65M -30.95M-11.31% Q1 2022 307.5M 286.41M 21.09M7.36% Q4 2021 723.2M 698.27M 24.93M3.57% Q3 2021 329M 491.71M -162.71M-33.09% Q2 2021 397.5M 402.92M -5.42M-1.35% Q1 2021 343M 362.06M -19.06M-5.26% Q4 2020 583M 569.58M 13.42M2.36%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 1.209B 1.793B -32.56%Q4 2022 313.26M 723.2M -56.68%FY 2023 1.244B 1.209B 2.89%Q1 2023 247.01M 307.5M -19.67%Q2 2023 325.73M 242.7M 34.21%Q3 2023 273.91M 240M 14.13%Q4 2023 337.81M 313.26M 7.84%FY 2024 1.26B 1.244B 1.29%FY 2025 1.26B 1.26B 0.00%FY 2026 1.263B 1.26B 0.24%